| 1 |
35573297 | Supporting Cells and Their Potential Roles in Cisplatin-Induced Ototoxicity. | 2022 |
1 |
| 2 |
33404748 | Dual-mode imaging of copper transporter 1 in HepG2 cells by hyphenating confocal laser scanning microscopy with laser ablation ICPMS. | 2021 Feb |
4 |
| 3 |
33727814 | Overcoming Radiation Resistance by Iron-Platinum Metal Alloy Nanoparticles in Human Copper Transport 1-Overexpressing Cancer Cells via Mitochondrial Disturbance. | 2021 |
2 |
| 4 |
34275285 | Tumor-Specific ONOO- Nanogenerator for Improved Drug Delivery and Enhanced Chemotherapy of Tumor. | 2021 Jul 18 |
1 |
| 5 |
34521054 | ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. | 2021 Sep |
1 |
| 6 |
32207235 | PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1. | 2020 May |
1 |
| 7 |
32704405 | Evaluation of non-small cell lung cancer by PET/CT with 64CuCl2: initial experience in humans. | 2020 |
2 |
| 8 |
30614075 | Core fucosylation of copper transporter 1 plays a crucial role in cisplatin-resistance of epithelial ovarian cancer by regulating drug uptake. | 2019 May |
12 |
| 9 |
30959888 | CRISP-R/Cas9 Mediated Deletion of Copper Transport Genes CTR1 and DMT1 in NSCLC Cell Line H1299. Biological and Pharmacological Consequences. | 2019 Apr 6 |
2 |
| 10 |
31050072 | Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1. | 2019 Jul |
5 |
| 11 |
31779287 | The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells. | 2019 Nov 26 |
1 |
| 12 |
32665841 | Mice with a Sertoli cell-specific knockout of the Ctr1 gene exhibit a reduced sensitivity to cisplatin-induced testicular germ cell apoptosis. | 2019 Nov 1 |
1 |
| 13 |
28382507 | Cisplatin nephrotoxicity: a review of the literature. | 2018 Feb |
2 |
| 14 |
29152741 | NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1. | 2018 Jun |
4 |
| 15 |
29301278 | Theaflavin-3,3'-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells. | 2018 Jan 2 |
3 |
| 16 |
29479997 | Correlation of Expression Levels of Copper Transporter 1 and Thymidylate Synthase with Treatment Outcomes in Patients with Advanced Non-small Cell Lung Cancer Treated with S-1/Carboplatin Doublet Chemotherapy | 2018 Feb 26 |
2 |
| 17 |
29737086 | [Basic Research of the Adenovirus-mediated hCTR1 Transfection on the Treatment of Cisplatin Resistant Cervical Cancer]. | 2018 Jan |
4 |
| 18 |
29772714 | Modulating Chemosensitivity of Tumors to Platinum-Based Antitumor Drugs by Transcriptional Regulation of Copper Homeostasis. | 2018 May 16 |
1 |
| 19 |
29954488 | Glutaryl Polyamidoamine Dendrimer for Overcoming Cisplatin-Resistance of Breast Cancer Cells. | 2018 Oct 1 |
1 |
| 20 |
30195880 | Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop. | 2018 Sep 15 |
6 |
| 21 |
31938179 | Rapid diagnosis of cisplatin-sensitive and resistant cervical squamous cell carcinomas by reverse transcription loop-mediated isothermal amplification. | 2018 |
4 |
| 22 |
27980217 | The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets. | 2017 Feb 28 |
2 |
| 23 |
28383086 | Platinum transfer from hCTR1 to Atox1 is dependent on the type of platinum complex. | 2017 May 24 |
4 |
| 24 |
28516214 | Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells. | 2017 Jul |
3 |
| 25 |
26906901 | Platinum (IV)-fatty acid conjugates overcome inherently and acquired Cisplatin resistant cancer cell lines: an in-vitro study. | 2016 Feb 23 |
3 |
| 26 |
27112899 | Dual role of LRRC8A-containing transporters on cisplatin resistance in human ovarian cancer cells. | 2016 Jul |
1 |
| 27 |
27157188 | Copper transporters and chaperones CTR1, CTR2, ATOX1, and CCS as determinants of cisplatin sensitivity. | 2016 Sep 1 |
1 |
| 28 |
27172866 | Effects of Cu(II) and cisplatin on the stability of Specific protein 1 (Sp1)-DNA binding: Insights into the regulation of copper homeostasis and platinum drug transport. | 2016 Aug |
3 |
| 29 |
27270317 | NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells. | 2016 Jul 12 |
3 |
| 30 |
27877224 | The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC). | 2016 |
1 |
| 31 |
25823781 | Human OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity. | 2015 |
1 |
| 32 |
25927922 | EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer. | 2015 |
5 |
| 33 |
25964760 | Role of transporters in the distribution of platinum-based drugs. | 2015 |
1 |
| 34 |
26004625 | Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. | 2015 |
2 |
| 35 |
26121483 | Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer. | 2015 |
2 |
| 36 |
26235215 | The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex. | 2015 Dec |
4 |
| 37 |
26637863 | Molecular Docking Analysis of Steroid-based Copper Transporter 1 Inhibitors. | 2015 Dec |
4 |
| 38 |
23988033 | Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells. | 2014 |
1 |
| 39 |
24132751 | Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals. | 2014 Jan |
6 |
| 40 |
24403514 | Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer. | 2014 Jan |
1 |
| 41 |
24447817 | Characterization of a monoclonal antibody capable of reliably quantifying expression of human Copper Transporter 1 (hCTR1). | 2014 Apr |
2 |
| 42 |
24522273 | Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin. | 2014 Mar |
2 |
| 43 |
24967972 | Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4. | 2014 Aug 15 |
3 |
| 44 |
25091475 | Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model. | 2014 Oct |
3 |
| 45 |
25594011 | Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. | 2014 |
2 |
| 46 |
23053666 | Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. | 2013 Jan |
1 |
| 47 |
23482746 | Progesterone and estrogen prevent cisplatin-induced apoptosis of lung cancer cells. | 2013 Mar |
1 |
| 48 |
23642142 | Interaction between platinum complexes and the C-terminal motif of human copper transporter 1. | 2013 May 20 |
4 |
| 49 |
23879689 | A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment. | 2013 Sep |
12 |
| 50 |
24122978 | Overcoming platinum drug resistance with copper-lowering agents. | 2013 Oct |
1 |